PDL BIOPHARMA, INC.
CIK 882104 · View on SEC EDGAR ↗
Insider
First SEC filing: Sept. 17, 2020 · Latest: Sept. 17, 2020
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 1 non-open-market transaction below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
1 other filing hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 29, 2020 | LNSR | P | 8,703 | $11.16 | $97,125 | 8,667,397 Direct | +0.10% | Acquired | -23.7% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 17, 2020 | LNSR | Common Stock | 8,658,694 | Direct |